These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26161475)

  • 21. Hfq, a novel pleiotropic regulator of virulence-associated genes in Francisella tularensis.
    Meibom KL; Forslund AL; Kuoppa K; Alkhuder K; Dubail I; Dupuis M; Forsberg A; Charbit A
    Infect Immun; 2009 May; 77(5):1866-80. PubMed ID: 19223477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of branched-chain amino acid utilization in Francisella intracellular adaptation.
    Gesbert G; Ramond E; Tros F; Dairou J; Frapy E; Barel M; Charbit A
    Infect Immun; 2015 Jan; 83(1):173-83. PubMed ID: 25332124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.
    Horzempa J; Carlson PE; O'Dee DM; Shanks RM; Nau GJ
    BMC Microbiol; 2008 Oct; 8():172. PubMed ID: 18842136
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Brock SR; Parmely MJ
    Front Cell Infect Microbiol; 2017; 7():523. PubMed ID: 29312899
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.
    Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI
    Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection.
    Babadjanova Z; Wiedinger K; Gosselin EJ; Bitsaktsis C
    PLoS One; 2015; 10(6):e0129981. PubMed ID: 26114641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist.
    Walters KA; Olsufka R; Kuestner RE; Wu X; Wang K; Skerrett SJ; Ozinsky A
    BMC Genomics; 2015 Oct; 16():874. PubMed ID: 26510639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages.
    Maier TM; Casey MS; Becker RH; Dorsey CW; Glass EM; Maltsev N; Zahrt TC; Frank DW
    Infect Immun; 2007 Nov; 75(11):5376-89. PubMed ID: 17682043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
    Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
    Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection.
    Bar-Haim E; Gat O; Markel G; Cohen H; Shafferman A; Velan B
    PLoS Pathog; 2008 Nov; 4(11):e1000211. PubMed ID: 19023422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2.
    Qin A; Mann BJ
    BMC Microbiol; 2006 Jul; 6():69. PubMed ID: 16879747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human macrophage-hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica.
    Rennert K; Otto P; Funke H; Huber O; Tomaso H; Mosig AS
    BMC Microbiol; 2016 Jan; 16():2. PubMed ID: 26739172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
    Gentry M; Taormina J; Pyles RB; Yeager L; Kirtley M; Popov VL; Klimpel G; Eaves-Pyles T
    Infect Immun; 2007 Aug; 75(8):3969-78. PubMed ID: 17502386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis.
    Forslund AL; Kuoppa K; Svensson K; Salomonsson E; Johansson A; Byström M; Oyston PC; Michell SL; Titball RW; Noppa L; Frithz-Lindsten E; Forsman M; Forsberg A
    Mol Microbiol; 2006 Mar; 59(6):1818-30. PubMed ID: 16553886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Single Mechanosensitive Channel Protects Francisella tularensis subsp. holarctica from Hypoosmotic Shock and Promotes Survival in the Aquatic Environment.
    Williamson DR; Dewan KK; Patel T; Wastella CM; Ning G; Kirimanjeswara GS
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269496
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.
    D'Elia RV; Laws TR; Núñez A; Taylor C; Clark GC
    Microb Pathog; 2015 Jan; 78():37-42. PubMed ID: 25284816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression.
    Chong A; Wehrly TD; Nair V; Fischer ER; Barker JR; Klose KE; Celli J
    Infect Immun; 2008 Dec; 76(12):5488-99. PubMed ID: 18852245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.